Apple has spent years and millions of dollars trying to crack one of wearable technology’s biggest health challenges: noninvasive blood glucose monitoring for Apple Watch. Now, a promising new gadget…
On January 6th, 2026, Encellin (California, Quebec) reported positive interim results of its Phase 1 clinical trial of encapsulated islets in people with type 1 diabetes (T1D), which is being carried…
A shoebox-sized optical device reads glucose directly through the skin in seconds, offering a promising step toward truly noninvasive, point-of-care glucose monitoring. Pipeline for the development of compact BRS-based CGM.…
CureusUse of the RETeval™ Handheld Electroretinogram Device for Assessing the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes: A Case ReportDiabetic retinopathy (DR) is the most common and…
INDIANAPOLIS, Ind. (Ivanhoe Newswire) – More than 38 million Americans have diabetes and regular blood sugar monitoring is crucial. A team of researchers is working on a new way to…